The company's stock has fallen sharply since it announced the Medicare ratings downgrade. On Oct. 1, the stock opened at $315. After the ruling Friday, the company's stock was down 2% to $219.04.

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

Humana (HUM) reportedly lost its legal challenge to overturn a decision that slashed its Medicare Advantage bonus payments, ...

Humana (HUM) stock falls as the company loses a lawsuit over its 2025 Medicare Star Ratings cut. Read more here.

Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...

Humana Inc. lost its lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped ...

A Texas federal judge dismissed a lawsuit brought by health insurer Humana challenging the U.S. government's reduction in its ...

A Texas federal judge dismissed a lawsuit brought by health insurer Humana challenging the U.S. Department of Health and ...

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

Jim Hutchinson, 78, gears up for the 2025 National Senior Games, illustrating his lifelong passion for running and dedication ...